Clinical Trial Info

Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)

Authored by
Staff

A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-Human Study of the Safety and Immunogenicity of AdCOVID Administered as One or Two Doses